State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Department of Gastroenterology, The first naval hospital of southern theater command, Zhanjiang, Guangdong, China .
Am J Gastroenterol. 2024 Oct 1;119(10):2028-2035. doi: 10.14309/ajg.0000000000002813. Epub 2024 Apr 15.
Fully covered self-expandable metal stents (FCSEMSs) are commonly placed in patients with biliary stricture during endoscopic retrograde cholangiopancreatography (ERCP). However, up to 40% of migration has been reported, resulting in treatment failure or the requirement for further intervention. Here, we aimed to investigate the effects of metal clip anchoring on preventing the migration of FCSEMS.
Consecutive patients requiring placement of FCSEMS were included in this multicenter randomized trial. The enrolled patients were randomly assigned in a 1:1 ratio to receive clip anchoring (clip group) or not (control group). The primary outcome was the migration rate at 6 months after stent insertion. The secondary outcomes were the rates of proximal and distal migration and stent-related adverse events. The analysis followed the intention-to-treat principle.
From February 2020 to November 2022, 180 patients with biliary stricture were enrolled, with 90 in each group. The baseline characteristics were comparable between the 2 groups. The overall rate of stent migration at 6 months was significantly lower in the clip group compared with the control group (16.7% vs 30.0%, P = 0.030). The proximal and distal migration rates were similar in the 2 groups (2.2% vs 5.6%, P = 0.205; 14.4% vs 22.2%, P = 0.070). Notably, none of the patients (0/8) who received 2 or more clips experienced stent migration. There were no significant differences in stent-related adverse events between the 2 groups.
Our data suggest that clip-assisted anchoring is an effective and safe method for preventing migration of FCSEMS without increasing the adverse events.
在经内镜逆行胰胆管造影术(ERCP)中,完全覆膜自膨式金属支架(FCSEMS)通常用于治疗胆管狭窄的患者。然而,高达 40%的支架迁移率的报道导致治疗失败或需要进一步干预。在此,我们旨在研究金属夹固定对预防 FCSEMS 迁移的影响。
这项多中心随机试验纳入了需要放置 FCSEMS 的连续患者。将入组患者以 1:1 的比例随机分为夹固定组(夹组)或不夹固定组(对照组)。主要结局是支架置入后 6 个月的迁移率。次要结局是近端和远端迁移率以及与支架相关的不良事件。分析遵循意向治疗原则。
2020 年 2 月至 2022 年 11 月,共纳入 180 例胆管狭窄患者,每组 90 例。两组患者的基线特征相似。夹组的支架总体迁移率在 6 个月时明显低于对照组(16.7%比 30.0%,P = 0.030)。两组近端和远端迁移率相似(2.2%比 5.6%,P = 0.205;14.4%比 22.2%,P = 0.070)。值得注意的是,接受 2 个或更多夹子固定的患者无一例发生支架迁移(0/8)。两组间支架相关不良事件无显著差异。
我们的数据表明,夹辅助固定是一种预防 FCSEMS 迁移的有效且安全的方法,不会增加不良事件。